SCHEMBL627767

SCHEMBL627767

O=C1CCCN1c1nn2cc(I)nc2s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.44
ALDH1A1 P00352 7/20 0.35
HPGD P15428 2/20 0.34
NPC1 O15118 4/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HRH3 Q9Y5N1 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
USP2 O75604 2/20 0.32
HTT P42858 1/20 0.32
ATM Q13315 1/20 0.32
RAB9A P51151 4/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KDM4E B2RXH2 1/20 0.32
PKM P14618 1/20 0.32
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL627766 0.73 L3MBTL1 (0.40) L3MBTL1ALDH1A1HPGDNPC1MEN1
SCHEMBL626698 0.72 CYP11B2 (0.52) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL624035 0.71 SMN1; SMN2 (0.40) ALDH1A1HPGDNPC1SMN1; SMN2USP2
SCHEMBL628000 0.69 MAPT (0.42) POLBLMNAMAPT
SCHEMBL16528490 0.66 MEN1 (0.49) L3MBTL1ALDH1A1HPGDNPC1MEN1
SCHEMBL452503 0.66 F2RL3 (0.42)
SCHEMBL627055 0.65 MAPT (0.48) MEN1KMT2ASMN1; SMN2KDM4ELMNA
SCHEMBL627088 0.64 MAPT (0.32) MAPT
SCHEMBL627112 0.62 F2RL3 (0.34)
SCHEMBL3550329 0.62 L3MBTL1 (0.61) L3MBTL1ALDH1A1HPGDNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed